Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: A clinical decision-support tool from The North American Menopause Society

Menopause

Volumn 22, Issue 3, 2015, Pages 247-253

  Manson, JoAnn E ^a   Ames, Jeffrey M ^b   Shapiro, Marla ^c   Gass, Margery L S ^d   Shifren, Jan L ^a   Stuenkel, Cynthia A ^e   Pinkerton, JoAnn V ^f   Kaunitz, Andrew M ^g   Pace, Diane T ^h   Kagan, Risa ^e   Schnatz, Peter F ⁱ   Kingsberg, Sheryl A ^d   Liu, James H ^d   Joffe, Hadine ^a   Richard Davis, Gloria ^j   Goldstein, Steven R ^k   Schiff, Isaac ^a   Utian, Wulf H ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

^g UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF MEMPHIS   (United States)

ⁱ THOMAS JEFFERSON UNIVERSITY   (United States)

^j UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^k NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; DECISION SUPPORT SYSTEM; FEMALE; HIGH RISK PATIENT; HORMONAL THERAPY; HUMAN; MEDICAL DECISION MAKING; MEDICAL SOCIETY; MENOPAUSAL SYNDROME; MENOPAUSE; MOBILE APPLICATION; PATIENT SAFETY; REVIEW; RISK ASSESSMENT; RISK FACTOR; DECISION MAKING; ESTROGEN THERAPY;

ALGORITHMS; DECISION MAKING; DECISION MAKING, COMPUTER-ASSISTED; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; MOBILE APPLICATIONS; SOCIETIES, MEDICAL;

EID: 84924293625     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000373     Document Type: Review

References (10)

1. Manson JE, Bassuk SS. The menopause transition and postmenopausal hormone therapy. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jamison JL, Loscalzo J, eds. Harrison's Principles of Internal Medicine, McGraw-Hill: New York, 2011.
2. North American Menopause Society. The 2012 Hormone Therapy Position Statement of the North American Menopause Society. Menopause 2012;19:257-271.
3. North American Menopause Society. Menopause Practice: A Clinician-s Guide, 5th ed. 2014.
4. Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA 2013;310:1353-1368.
5. Santen RJ, Allred DC, Ardoin SP, et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 2010;95(Suppl 1):s1-s66.
6. Bray PF, Larson JC, Lacroix AZ, et al. Usefulness of baseline lipids and Creactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary events. Am J Cardiol 2008;101:1599-1605.
7. Wild RA, Wu C, Curb JD, et al. Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested caseYcontrol study within the Women's Health Initiative randomized clinical trials. Menopause 2013;20:254-260.
8. Manson JE. The role of personalized medicine in identifying appropriate candidates for menopausal estrogen therapy. Metabolism 2013; 62(Suppl 1):S15-S19.
9. Bassuk SS, Manson JE. Menopausal hormone therapy and cardiovascular disease risk: utility of biomarkers and clinical factors for risk stratification. Clin Chem 2014;60:68-77.
10. Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 01.cir.0000437741.48606.98 published online before print November 12 2013. The online-only Data Supplement is available with this article at http://circ.ahajournals.org/ lookup/suppl/doi:10.1161/01.cir.0000437741.48606.98/-/DC1.